Evolent Health in sale talks after drawing interest: Reuters By Investing.com

Investing.com — Evolent Health, a $3.3 billion market value healthcare provider, is in talks with private equity firms and other companies for a potential sale, Reuters reported on Thursday, citing people familiar with the matter. with the matter.

Private equity firms TPG, CD&R and KKR are among those interested in a deal for Evolent.

Bidders include health insurer Elevance Health Inc (NYSE: ) and may team up with a private equity firm to make a bid for the healthcare provider, the sources told Reuters.

Evolent has engaged the services of a financial advisor to assist with the sale process and has already received initial offers. Sources suggest a deal could be completed in the next few weeks.

The sources, however, who spoke on condition of anonymity because of the confidential nature of the discussions, cautioned that there was no guarantee a deal would materialize.

Actions of Evolent Health Inc (NYSE: ) jumped 17% in recent trading on the news.